课题基金 / 基金详情

MOLECULAR MECHANISMS OF TRANSFORMATION BY AP-1 PROTEINS

MOLECULAR MECHANISMS OF TRANSFORMATION BY AP-1 PROTEINS
AP-1 蛋白质转化的分子机制
批准号:
6150181
负责人:
RONALD M WISDOM
金额:
$25.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-03 至 2000-11-08

项目摘要

项目成果

RONALD M WISDOM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (adapted from the investigator's abstract) Molecular, genetic, and biochemical characterization has demonstrated that the transcription factor AP-1, which is composed of dimeric complexes of Fos and Jun proteins, regulates cellular responses to diverse extracellular stimuli. AP-1 participates in the conversion of cells from normal to malignant growth in at least two separate contexts. First, genes of the Fos and Jun family can serve as the primary targets of mutational activation, as in the case of Fos and Jun containing oncogenic retroviruses. In addition, AP-1 proteins can function as effectors of transformation by several different cytoplasmic oncoproteins, many of which are common targets of mutational activation in human cancers. In addition to playing a role in mediating transformation, they have shown by genetic analysis that AP-1 proteins in general, and c-Jun in particular, play important roles in two cellular processes that may be related to the ability to effect oncogenic changes: in fibroblasts, c-Jun is required for normal cell cycle progression and protects cells from apoptosis in response to two different apoptotic stimuli, U/V irradiation and the cytokine TNF. Their long term goal is to understand in molecular detail the normal functions of AP-1 proteins and how deregulation of this transcription factor contributes to the development of cancer. To reach this goal, they propose experiments to address the following questions: 1) role does phosphorylation of FosB protein (and Fos proteins in general) play in the regulation of transcriptional activation and neoplastic transformation? 2) What are the kinases that mediate phosphorylation at functionally important sites, and how are they regulated? 3) What is the role of c-Jun, JNK, and the JNK/cJun interaction in the control of neoplastic transformation, cell proliferation, and apoptosis? 4) How is the AP-1 responsiveness of the cyclin D1 promoter regulated so that it is not induced by anti-proliferative stimuli that activate AP-1, such as U/V irradiation? They propose a series of genetic, biochemical, and cell biologic experiments to address these issues. The answers to these questions will increase our understanding of the molecular basis of transformation by AP-1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR MECHANISMS OF TRANSFORMATION BY AP-1 PROTEINS
MOLECULAR MECHANISMS OF TRANSFORMATION BY AP 1 PROTEINS
  • 批准号:
    2106388
  • 项目类别:
  • 资助金额:
    $20.2万
  • 财政年份:
    1995
  • 负责人:
    RONALD M WISDOM
  • 依托单位:
MOLECULAR MECHANISMS OF TRANSFORMATION BY AP 1 PROTEINS
  • 批准号:
    2106389
  • 项目类别:
  • 资助金额:
    $20.31万
  • 财政年份:
    1995
  • 负责人:
    RONALD M WISDOM
  • 依托单位:
MOLECULAR MECHANISMS OF TRANSFORMATION BY AP-1 PROTEINS
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: